Weight Maintenance After GLP-1 Discontinuation Analysis

This report presents an analysis of weight maintenance among members who discontinued GLP-1 medications within the Omada Enhanced GLP-1 Care Track. The analysis focuses on the outcomes observed 16 weeks post-discontinuation. It highlights that members experienced an average weight change of -0.1%, indicating successful weight maintenance. The report details that 63.5% of participants experienced less than 2% weight gain, while 84.1% experienced less than 4% weight gain since discontinuation. The findings underscore the challenges faced by patients in maintaining weight loss after stopping GLP-1s, including emotional factors and access issues. The Enhanced GLP-1 Care Track offers tailored support, including health coaching and community resources, which may contribute to better weight maintenance outcomes. The report emphasizes the importance of real-world evidence in understanding the effectiveness of GLP-1s and the need for comprehensive support systems to assist patients in their weight health journeys.